Goldman Sachs Initiates Coverage On Humana with Neutral Rating, Announces Price Target of $472
Goldman Sachs analyst Nathan Rich initiates coverage on Humana (NYSE:HUM) with a Neutral rating and announces Price Target of $472.
Here’s How Much You Would Have Made Owning Humana Stock In The Last 20 Years
Humana (NYSE:HUM) has outperformed the market over the past 20 years by 12.53% on an annualized basis.
Humana Announces Value-Based Agreement With Allina Health In Minnesota; Terms Not Disclosed
Humana Inc. (NYSE:HUM), a leading health and well-being company, and Allina Health are expanding their existing agreement to focus on value-based care for Humana's Medicare Advantage members in Minnesota.
This
Deutsche Bank Maintains Hold on Humana, Raises Price Target to $476
Deutsche Bank maintains Humana (NYSE:HUM) with a Hold and raises the price target from $456 to $476.
Expert Ratings For Humana
Within the last quarter, Humana (NYSE:HUM) has observed the following analyst ratings:
Oppenheimer Maintains Outperform on Humana, Raises Price Target to $510
Oppenheimer analyst Michael Wiederhorn maintains Humana (NYSE:HUM) with a Outperform and raises the price target from $480 to $510.
Morgan Stanley Maintains Overweight on Humana, Raises Price Target to $559
Morgan Stanley analyst Ricky Goldwasser maintains Humana (NYSE:HUM) with a Overweight and raises the price target from $513 to $559.
Humana Cuts FY21 Earnings Outlook Reflecting Net COVID Headwind
Humana Inc (NYSE:HUM) posts Q3 sales of $20.87 billion, missing the consensus of $20.91 billion. 3Q21 and YTD 2021 results…
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.